Alkali Therapy in Chronic Kidney Disease

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

149

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

August 31, 2016

Study Completion Date

August 31, 2016

Conditions
Chronic Kidney DiseaseMetabolic Acidosis
Interventions
DRUG

Sodium bicarbonate

0.4 mEq/kg/day ideal body weight to be taken once a day

DRUG

Placebo

To be taken on the same schedule as the active arm

Trial Locations (2)

10461

Albert Einstein College of Medicine, The Bronx

44106

Case Western Reserve University, Cleveland

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

collaborator

National Institutes of Health (NIH)

NIH

lead

Albert Einstein College of Medicine

OTHER

NCT01452412 - Alkali Therapy in Chronic Kidney Disease | Biotech Hunter | Biotech Hunter